• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM JET7 REPERFUSION CATHETER; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM JET7 REPERFUSION CATHETER; HCG, KRD Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vasoconstriction (2126)
Event Date 07/12/2020
Event Type  malfunction  
Manufacturer Narrative
The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.Potential adverse events in the labeling with the penumbra system include, but are not limited to, hematoma or hemorrhage at the site,vessel spasm, inability to completely remove thrombus, intracranial hemorrhage, ischemia, including death.Therefore, it was determined that the reported adverse events were anticipated complications.The product lot number was not provided, therefore, the manufacturing records could not be reviewed.
 
Event Description
On (b)(6) 2020, the patient underwent a thrombectomy procedure in the right middle cerebral artery (mca) and right internal carotid artery (ica) using a penumbra system jet 7 reperfusion catheter (jet7).During the procedure, the physician completed two passes using the jet7.Afterwards, the physician performed a digital subtraction angiography (dsa) through the jet7 in the right internal carotid artery (ica) resulting thrombolysis in cerebral infarction (tici) 3; however, the physician noticed vasospasm in the right mca.The physician infused 10mg of intra-arterial verapamil through the jet7 in the right ica using a slow hand bolus technique over approximately 10 minutes.Post verapamil infusion, the physician performed another digital subtraction angiography (dsa) showing correction of the vasospasm.The event was considered resolved the same day with the infusion of verapamil.The vasospasm was reported to be a non-serious adverse event with a definite relationship to the index procedure and jet7.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM JET7 REPERFUSION CATHETER
Type of Device
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key11405450
MDR Text Key241504051
Report Number3005168196-2021-00392
Device Sequence Number1
Product Code HCG
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K173761
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/01/2005,02/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received02/01/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-